位置:成果数据库 > 期刊 > 期刊详情页
11-羰基-β-乙酰乳香酸抗氧化胃保护作用及机制研究
  • ISSN号:1673-6273
  • 期刊名称:《现代生物医学进展》
  • 时间:0
  • 分类:R-33[医药卫生] R573.1[医药卫生—消化系统;医药卫生—临床医学;医药卫生—内科学]
  • 作者机构:[1]陕西省结核病防治院,陕西西安710100, [2]第四军医大学西京医院药剂科,陕西西安710032, [3]沈阳军区总医院药剂科,辽宁沈阳110016
  • 相关基金:国家自然科学基金项目(81373947;81201985)
中文摘要:

目的:研究11-羰基-β-乙酰乳香酸(AKBA)的抗氧化作用及胃保护效果.方法:30只SD大鼠随机分为5组:正常组(生理盐水5 mL/kg),模型组(吲哚美辛48 mg/kg),西咪替丁组(100 mg/kg),低剂量AKBA组(100 mg/kg),高剂量AKBA组(200mg/kg).预给药1小时后,用吲哚美辛(48mg/kg)灌胃造模,评价溃疡指数(UI)、胃内容物酸度(pH)、胃壁黏液量(GWM)、前列腺素E2(PGE-2)及一氧化氮(NO)的含量,并检测超氧化物歧化酶(SOD)、过氧化氢酶(CAT)的活性,丙二醛(MDA)含量及核转录相关因子2(Nrt2)和血红素加氧酶1(HO-1)的表达量.结果:①与造模组相比,AKBA高剂量组(P<0.05)与西咪替丁组(P<0.001)显著降低了吲哚美辛诱导的胃粘膜损伤,AKBA低剂量组的差异无统计学意义;②AKBA与西咪替丁均显著升高胃内容物pH(P<0.001)(AKBA低剂量组P<0.05),增加GWM含量(P<0.001);③与造模组相比,AKBA及西咪替丁组均显著增高PGE-2及NO含量(P<0.001);④与造模组相比,AKBA及西咪替丁组均显著增高SOD活性(P<0.001)(AKBA低剂量组P<0.05)及CAT活性(P<0.001)并降低了MDA含量(P<0.001);⑤与造模组相比,AKBA高剂量组及西咪替丁组促进Nrf2及HO-1表达明显增高(P<0.05).结论:AKBA有较好的胃保护效果,同时可以通过升高GWM、降低胃内容物pH,升高NO含量,阻止PGE-2的降低,同时恢复SOD、CAT的活性,降低MDA含量,促进Nrt2及HO-1的表达发挥胃黏膜保护的作用.

英文摘要:

Objective:To investigate the protective effect and antioxidant effect of Acetyl-11-Keto-beta-Boswellic Acid (AKBA) in gastric injury in rats.Methods:All the 30 rats were divided evenly and randomly into the following 5 groups:control group (5 mL/kg physiological saline),model group (5 mL/kg physiological saline),cimetidine group (100 mg/kg),L-AKBA group (100 mg/kg) and H-AKBA group (200 mg/kg).One hour before administration of indomethacin,the vehicle,cimetidine and AKBA were given to each experimental group through administration by gavage.The gastro-protection effect was assessed by measuring ulcer index (UI),gastric juice acidity (pH),gastric wall mucus (GWM),prostaglandin E2 (PGE-2) and nitric oxide (NO).The antioxidant effects were measured through the activity of superoxide dismutase (SOD),catalase (CAT) and the level of MDA.Meanwhile,the expression of Erythroid-2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) were assessed.Results:① Compared with model group,UI was decreased significantly in H-AKBA group (P<0.05) and cimetidine group (P<0.001),while the difference between L-AKBA group and model group were not statistical significance;② Compared with model group,and the GWM were increased markedly in both AKBA groups and cimetidine group (P<0.001),and pH were increased in H-AKBA group,cimetidine group (P<0.001) and L-AKBA group (P<0.05);③ Compared with control group,the level of PGE-2 and NO were significantly increased in both AKBA groups and cimetidine group (P <0.001).④ Compared with model group,the activity of SOD and CAT were increased in H-AKBA group,cimetidine group (P<0.001),and in L-AKBA group (P<0.05).Besides,the level of MDA were decreased in both AKBA groups and cimetidine group (P<0.001).⑤ The expression of Nrf2 and HO-1 were increased in H-AKBA group,cimetidine group (P<0.05).Conclusions:The AKBA could protect gastric from injury through increasing GW

同期刊论文项目
同项目期刊论文
期刊信息
  • 《现代生物医学进展》
  • 中国科技核心期刊
  • 主管单位:黑龙江省卫生厅
  • 主办单位:黑龙江省红十字医院 黑黑龙江省红十字医院 黑龙江省森林工总医院
  • 主编:申宝忠
  • 地址:哈尔滨市南岗区花园街184号403
  • 邮编:150001
  • 邮箱:biomed_54@126.com
  • 电话:0451-82583800 53658268
  • 国际标准刊号:ISSN:1673-6273
  • 国内统一刊号:ISSN:23-1544/R
  • 邮发代号:14-12
  • 获奖情况:
  • 国内外数据库收录:
  • 被引量:33230